The value of psychological treatment for borderline personality disorder: Systematic review and cost offset analysis of economic evaluations

Denise Meuldijk, Alexandra McCarthy, Marianne E Bourke, Brin F S Grenyer, Denise Meuldijk, Alexandra McCarthy, Marianne E Bourke, Brin F S Grenyer

Abstract

Aim: Borderline Personality Disorder (BPD) is a common mental health condition with high patterns of service utilisation of inpatient and community treatment. Over the past five years there has been significant growth in research with economic data, making this systematic review a timely update.

Methods: Empirical studies written in English or German, published up to December 2015, and cited in major electronic databases were examined using the PRISMA systematic review method. Papers were included that had one of the following: data related to cost of BPD to society, the individual, the carer or families; cost benefits of interventions. Reported cost data were inflated to the year 2015 and converted into US- dollars (USD $) using purchasing power parities.

Results: We identified 30 economic evaluations providing cost data related to interventions for BPD across 134,136 patients. The methodological quality was good, almost all studies fulfilled ≥ 50% of the quality criteria. The mean cost saving for treating BPD with evidence-based psychotherapy across studies was USD $2,987.82 per patient per year. A further mean weighted reduction of USD $1,551 per patient per year (range $83 - $29,392) was found compared to treatment as usual. Evidence-based psychological treatment was both less expensive as well as more effective, despite considerable differences in health cost arrangements between individual studies and countries. Where it was able to be calculated, a significant difference in cost-savings between different types of evidence-based psychotherapies was found.

Discussion: Individuals with BPD consistently demonstrate high patterns of service utilization and therefore high costs. The findings of this review present a strong argument in favour of prioritizing BPD treatments in reimbursement decisions, both for the affected individual and the family. The provision of evidence based treatment, irrespective of the type of psychological treatment, may lead to widespread reductions in healthcare costs.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. PRISMA Flowchart for the selection…
Fig 1. PRISMA Flowchart for the selection of studies included in the systematic review.

References

    1. Rutten F (1996) Economic evaluation and health care decision-making. Health Policy 36: 215–229.
    1. Hoffmann C, Graf von der Schulenburg JM (2000) The influence of economic evaluation studies on decision making. A European survey. The EUROMET group. Health Policy 52: 179–192.
    1. van Asselt ADI, Dirksen CD, Arntz A, Severens JL (2007) The cost of borderline personality disorder: Societal cost of illness in BPD-patients. European Psychiatry 22: 354–361. 10.1016/j.eurpsy.2007.04.001
    1. Magnavita JJ, Levy KN, Critchfield KL, Lebow JL (2010) Ethical considerations in treatment of personality dysfunction: Using evidence, principles, and clinical judgment. Professional Psychology: Research and Practice 41: 64–74.
    1. Bender DS, Dolan RT, Skodol AE, Sanislow CA, Dyck IR, McGlashan TH, et al. (2001) Treatment utilization by patients with personality disorders. Am J Psychiatry 158: 295–302. 10.1176/appi.ajp.158.2.295
    1. Sansone RA, Farukhi S, Wiederman MW (2011) Utilization of primary care physicians in borderline personality. Gen Hosp Psychiatry 33: 343–346. 10.1016/j.genhosppsych.2011.04.006
    1. Soeteman DI, Hakkaart-van Roijen L, Verheul R, Busschbach JJ (2008) The economic burden of personality disorders in mental health care. J Clin Psychiatry 69: 259–265.
    1. Gunderson JG (2009) Borderline personality disorder: ontogeny of a diagnosis. Am J Psychiatry 166: 530–539. 10.1176/appi.ajp.2009.08121825
    1. Leichsenring F, Leibing E, Kruse J, New AS, Leweke F (2011) Borderline personality disorder. Lancet 377: 74–84. 10.1016/S0140-6736(10)61422-5
    1. Torgersen S, Kringlen E, Cramer V (2001) The prevalence of personality disorders in a community sample. Arch Gen Psychiatry 58: 590–596.
    1. American Psychological Association (APA) (2001) Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. Am J Psychiatry 158: 1–52.
    1. Amianto F, Ferrero A, Piero A, Cairo E, Rocca G, Simonelli B, et al. (2011) Supervised team management, with or without structured psychotherapy, in heavy users of a mental health service with borderline personality disorder: a two-year follow-up preliminary randomized study. BMC Psychiatry 11: 181 10.1186/1471-244X-11-181
    1. Dimeff LA, & Koerner K. (2007) Dialectical Behaviour Therapy in Clinical Practice: Applications across Disorders and Settings.: New York, NY: Guildford.
    1. Jackson HJ, Burgess PM (2004) Personality disorders in the community: results from the Australian National Survey of Mental Health and Well-being Part III. Relationships between specific type of personality disorder, Axis 1 mental disorders and physical conditions with disability and health consultations. Soc Psychiatry Psychiatr Epidemiol 39: 765–776.
    1. Borschmann R, Henderson C, Hogg J, Phillips R, Moran P (2012) Crisis interventions for people with borderline personality disorder. Cochrane Database Syst Rev: CD009353 10.1002/14651858.CD009353.pub2
    1. Grenyer BF (2013) Improved prognosis for borderline personality disorder. Med J Aust 198: 464–465.
    1. Brazier J, Tumur I, Holmes M, Ferriter M, Parry G, Dent-Brown K, et al. (2006) Psychological therapies including dialectical behaviour therapy for borderline personality disorder: A systematic review and preliminary economic evaluation. Health Technology Assessment 10: 1–61.
    1. Brettschneider C, Riedel-Heller S, Konig HH (2014) A systematic review of economic evaluations of treatments for borderline personality disorder. PLoS One 9: e107748 10.1371/journal.pone.0107748
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6: e1000100 10.1371/journal.pmed.1000100
    1. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F (1998) Systematic reviews of trials and other studies. Health Technol Assess 2: 1–276.
    1. Drummond M, Manca A, Sculpher M (2005) Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care 21: 165–171.
    1. Luyten J, Naci H, Knapp M (2016) Economic evaluation of mental health interventions: an introduction to cost-utility analysis. Evid Based Ment Health 19: 49–53. 10.1136/eb-2016-102354
    1. Evers S, Goossens M, de Vet H, van Tulder M, Ament A (2005) Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. Int J Technol Assess Health Care 21: 240–245.
    1. Organisation for Economic Co-operation and Development (OECD) (2013) OECD Health Data: Economic references.
    1. Bateman A, Fonagy P (2003) Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care. Am J Psychiatry 160: 169–171. 10.1176/appi.ajp.160.1.169
    1. Palmer S, Davidson K, P, Gumley A, Tata P, Norrie J, et al. (2006) The cost-effectieveness of cognitive behavior therapy for borderline personality disorder: Results from the BOSCOT trial. Journal of Personality Disorders 20: 466–481. 10.1521/pedi.2006.20.5.466
    1. Goodman M, Patil U, Triebwasser J, Hoffman P, Weinstein ZA, New A (2011) Parental burden associated with borderline personality disorder in female offspring. Journal of Personality Disorders 25: 59–74. 10.1521/pedi.2011.25.1.59
    1. Amner K (2012) The effect of DBT provision in reducing the cost of adults displaying the symptoms of BPD. British Journal of Psychotherapy 28: 336–352.
    1. Meyers LL, Landes SJ, Thuras P (2014) Veterans’ service utilization and associated costs following participation in Dialectical Behavior Therapy: A preliminary investigation. Military Medicine 179: 1368–1373. 10.7205/MILMED-D-14-00248
    1. Perseius K-I, Samuelsson M, Andersson E, Berndtsson T, Götmark H, Henriksson F, et al. (2004) Does Dialectical Behavioural Therapy Reduce Treatment Costs for Patients with Borderline Personality Disorder. A Pilot Study. Nordic Journal of Nursing Research 24: 27–30.
    1. Wagner T, Fydrich T, Stiglmayr C, Marschall P, Salize H-J, Renneberg B, et al. (2014) Societal cost-of-illness in patients with borderline personality disorder one year before, during and after dialectical behavior therapy in routine outpatient care. Behaviour Research and Therapy 61: 12–22. 10.1016/j.brat.2014.07.004
    1. Turner RM (2000) Naturalistic evaluation of dialectical behavior therapy-oriented treatment for borderline personality disorder. Cognitive and Behavioral Practice 7: 413–419.
    1. Heard HL (2000) Cost-effectiveness of dialectial behaviour therapy in the treatment of borderline personality disorder. (Doctor of Philosophy), University of Washington (9975993).
    1. Stevenson J, Meares R (1999) Psychotherapy with borderline patients: II. A preliminary cost benefit study. Australian and New Zealand Journal of Psychiatry 33: 473–477. 10.1080/j.1440-1614.1999.00595.x
    1. Hall J, Caleo S, Stevenson J, Meares R (2001) An Economic Analysis of Psychotherapy for Borderline Personality Disorder Patients. J Ment Health Policy Econ 4: 3–8.
    1. Turri MG, Andreatta L (2014) Does psychoanalytic psychotherapy offset use of mental health services and related costs in severe borderline personality disorder?—A case study. Psychoanalytic Psychotherapy 28: 139–158.
    1. Kvarstein EH, Arnevik E, Halsteinli V, Ro FG, Karterud S, Wilberg T (2013) Health service costs and clinical gains of psychotherapy for personality disorders: a randomized controlled trial of day-hospital-based step-down treatment versus outpatient treatment at a specialist practice. BMC Psychiatry 13: 315 10.1186/1471-244X-13-315
    1. Van Asselt ADI, Dirksen CD, Arntz A, Severens JL (2008) Difficulties in calculating productivity costs: Work disability associated with borderline personality disorder. Value in Health 11: 637–644. 10.1111/j.1524-4733.2007.00288.x
    1. Van Asselt ADI, Dirksen CD, Arntz A, Giesen-Bloo JH, Van Dyck R, Spinhoven P, et al. (2008) Out-patient psychotherapy for borderline personality disorder: Cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy. British Journal of Psychiatry 192: 450–457. 10.1192/bjp.bp.106.033597
    1. Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL (1991) Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 48: 1060–1064.
    1. van den Bosch LM, Verheul R, Schippers GM, van den Brink W (2002) Dialectical Behavior Therapy of borderline patients with and without substance use problems. Implementation and long-term effects. Addict Behav 27: 911–923.
    1. Koons CR, Robins CJ, Lindsey Tweed J, Lynch TR, Gonzalez AM, Morse JQ, et al. (2001) Efficacy of dialectical behavior therapy in women veterans with borderline personality disorder. Behavior Therapy 32: 371–390.
    1. Pasieczny N, Connor J (2011) The effectiveness of dialectical behaviour therapy in routine public mental health settings: An Australian controlled trial. Behaviour Research and Therapy 49: 4–10. 10.1016/j.brat.2010.09.006
    1. Prendergast NM, j. (2007) Dialectic Behaviour Therapy: A 12-Month Collaborative Program in a Local Community Setting. Behaviour Change 24: 25–35.
    1. Priebe S, Bhatti N, Barnicot K, Bremner S, Gaglia A, Katsakou C, et al. (2012) Effectiveness and cost-effectiveness of dialectical behaviour therapy for self-harming patients with personality disorder: A pragmatic randomised controlled trial. Psychotherapy and Psychosomatics 81: 356–365. 10.1159/000338897
    1. Richter C, Heinemann B, Kehn M, Steinacher B (2014) Effektivität der Dialektisch-Behavioralen Therapie (DBT) in der tagesklinischen Behandlung der Borderline-Persönlichkeitsstörung—Bedeutung von Medikation und Behandlungskosten. = Effectiveness of dialectical behavior therapy (DBT) in an outpatient clinic for borderline personality disorders—Impact of medication use and treatment costs. Psychiatrische Praxis 41: 148–152. 10.1055/s-0033-1343204
    1. Bateman A, Fonagy P (1999) Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry 156: 1563–1569. 10.1176/ajp.156.10.1563
    1. Berrino A, Ohlendorf P, Duriaux S, Burnand Y, Lorillard S, Andreoli A (2011) Crisis intervention at the general hospital: an appropriate treatment choice for acutely suicidal borderline patients. Psychiatry Res 186: 287–292. 10.1016/j.psychres.2010.06.018
    1. Borschmann R, Barrett B, Hellier JM, Byford S, Henderson C, Rose D, et al. (2013) Joint crisis plans for people with borderline personality disorder: Feasibility and outcomes in a randomised controlled trial. British Journal of Psychiatry 202: 357–364. 10.1192/bjp.bp.112.117762
    1. Tyrer P, Thompson S, Schmidt U, Jones V, Knapp M, Davidson K, et al. (2003) Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychological Medicine 33: 969–976.
    1. Davidson KM, P, Norrie J, Palmer SJ, H (2010) Cognitive therapy v. usual treatment for borderline personality disorder: Prospective 6-year follow-up. The British Journal of Psychiatry 197: 456–462. 10.1192/bjp.bp.109.074286
    1. Wagner T, Roepke S, Marschall P, Stiglmayr C, Renneberg B, Gieb D, et al. (2013) Societal cost-of-illness of borderline personality disorder. Zeitschrift Fur Klinische Psychologie Und Psychotherapie 42: 242–255.
    1. Bateman A, Fonagy P (2003) Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care. American Journal of Psychiatry 160: 169–171. 10.1176/appi.ajp.160.1.169
    1. Hall J, Caleo S, Stevenson J, Meares R (2001) An economic analysis of psychotherapy for borderline personality disorder patients. Journal of Mental Health Policy and Economics 4: 3–8.
    1. Bateman A, Fonagy P (2015) Borderline Personality Disorder and Mood Disorders: Mentalizing as a Framework for Integrated Treatment. J Clin Psychol 71: 792–804. 10.1002/jclp.22206
    1. Wunsch EM, Kliem S, Kroger C (2014) Population-based cost-offset estimation for the treatment of borderline personality disorder: projected costs in a currently running, ideal health system. Behav Res Ther 60: 1–7. 10.1016/j.brat.2014.06.002
    1. Schafer W, Kroneman M, Boerma W, van den Berg M, Westert G, Deville W, et al. (2010) The Netherlands: health system review. Health Syst Transit 12: v–xxvii, 1–228.
    1. Laurenssen EM, Smits ML, Bales DL, Feenstra DJ, Eeren HV, Noom MJ, et al. (2014) Day hospital Mentalization-based treatment versus intensive outpatient Mentalization-based treatment for patients with severe borderline personality disorder: protocol of a multicentre randomized clinical trial. BMC Psychiatry 14: 301 10.1186/s12888-014-0301-0
    1. van den Bosch LM, Sinnaeve R, Hakkaart-van Roijen L, van Furth EF (2014) Efficacy and cost-effectiveness of an experimental short-term inpatient Dialectical Behavior Therapy (DBT) program: study protocol for a randomized controlled trial. Trials 15: 152 10.1186/1745-6215-15-152
    1. Wetzelaer P, Farrell J, Evers SM, Jacob GA, Lee CW, Brand O, et al. (2014) Design of an international multicentre RCT on group schema therapy for borderline personality disorder. BMC Psychiatry 14: 319 10.1186/s12888-014-0319-3

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe